Therapy News and Research

RSS

Brain exhibits similar changes in both ADHD and emotional instability disorders

In both ADHD and emotional instability disorders (eg borderline and antisocial personality disorder as well as conduct disorder in children), the brain exhibits similar changes in overlapping areas, meaning that the two types of conditions should be seen as related and attention should be paid to both during diagnosis.

31 Aug 2018

New Euro-GASP program monitors continued effectiveness of treatment regimen for gonorrhea

Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme.

31 Aug 2018

NUS researchers harness AI platform to treat patient with advanced cancer

A translational research team led by the National University of Singapore has harnessed CURATE.AI, a powerful artificial intelligence platform, to successfully treat a patient with advanced cancer, completely halting disease progression. This new development represents a big step forward in personalized medicine.

31 Aug 2018

Simple intervention increases use of HIV medications in injection-drug users

A relatively simple effort to provide counseling and connect injection-drug users with resources could prove powerful against the spread of HIV in a notoriously hard-to-reach population, new research suggests.

31 Aug 2018

Subcutaneous injection of new protein helps treat hemophilia more effectively

Patients with hemophilia bleed spontaneously or following trauma. The most common sites of bleeding are into joints, but bleeds can also happen into any tissue in the body including the muscles, brain, or eyes.

31 Aug 2018

Single dose of cannabidiol showed effective results in rats with symptoms of depression

Commercial antidepressants typically take two to four weeks to have a significant effect on a depressed patient. They are also inneffective in approximately 40% of the cases.

31 Aug 2018

OSA patients have higher risk of developing gout, research reveals

New research reveals that people with obstructive sleep apnea (OSA) have a higher risk of developing gout, even beyond the first years after being diagnosed with the sleep disorder. The findings are published in Arthritis & Rheumatology, an official journal of the American College of Rheumatology.

30 Aug 2018

Pfizer terminates clinical studies evaluating domagrozumab for treatment of Duchenne muscular dystrophy

Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety and efficacy study (B5161002) and an open-label extension study (B5161004).

30 Aug 2018

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

Shionogi & Co., Ltd. announced today that Mulpleta (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure, is now available throughout the United States.

30 Aug 2018

HKBU chemists discover metal-based inhibitor to treat triple-negative breast cancer

Chemists at Hong Kong Baptist University have discovered the use of a metal compound that inhibits the enzyme closely associated with triple-negative breast cancer, one of the most difficult forms of breast cancer to treat.

30 Aug 2018

Philips announces inclusion of iFR into ESC’s updated revascularization guidelines

Royal Philips, a global leader in health technology, today announced that the European Society of Cardiology has incorporated instantaneous wave-free ratio into its updated revascularization guidelines.

30 Aug 2018

Ultralaser treatment reduces pain in patients with fibromyalgia

A new device that combines low-intensity laser light and therapeutic ultrasound considerably reduces the pain experienced by patients with fibromyalgia.

30 Aug 2018

New model could predict personalized waiting time for progression in colorectal cancer

An evolutionary model utilizing serial blood samples from patients with advanced colorectal cancer treated with anti-EGFR therapies in a phase II trial could predict personalized waiting time for progression.

30 Aug 2018

Scientists explore DNA replication errors that can lead to cancer

Scientists at Hollings Cancer Center at the Medical University of South Carolina have found that some cells can divide without a molecule that was previously thought necessary.

30 Aug 2018

Clinical trial: Promising drug slows brain shrinkage in progressive MS patients

A promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half, according to new research led by Cleveland Clinic. Very limited therapies are currently available for this disabling form of the disease.

30 Aug 2018

Cancer-hunting stem cells may be potential drug delivery tool for medulloblastoma

The latest in a series of laboratory breakthroughs could lead to a more effective way to treat the most common brain cancer in children.

30 Aug 2018

Two Texas-based nonprofits named as recipients of ASTRO 2018 Survivor Circle grants

Two Texas-based nonprofits, Candlelighters of El Paso and the Light and Salt Association, have been named the recipients of the American Society for Radiation Oncology2018 Survivor Circle grants. Each organization will receive a $10,000 grant to aid their cancer support programs and will be recognized at an award ceremony on October 23 during ASTRO's 60th Annual Meeting in San Antonio.

30 Aug 2018

Three-pronged therapy triggers axons to regrow after spinal cord injury in rodents

Neuroscientists at UCLA, Harvard University and the Swiss Federal Institute of Technology have identified a three-pronged treatment that triggers axons – the tiny fibers that link our nerve cells and enable them to communicate – to regrow after complete spinal cord injury in rodents. Not only did the axons grow through scars, they could also transmit signals across the damaged tissue.

29 Aug 2018

Study yields therapeutic clues to combat drug resistance in rare aggressive cancer

Stephen Elledge, PhD, and his team did not set out to find therapies that could render tumors less resistant to therapy or make existing drugs more potent against a rare form of cancer. But these are precisely the clinical insights that their most recent study has yielded.

29 Aug 2018

Novel program offers new options for adult congenital heart patients

Experts at the Vanderbilt Heart and Vascular Institute are forging new ground in the development of a first-of-its-kind program aimed at adults with congenital heart disease.

29 Aug 2018

Therapy News and Research

Brain exhibits similar changes in both ADHD and emotional instability disorders

New Euro-GASP program monitors continued effectiveness of treatment regimen for gonorrhea

NUS researchers harness AI platform to treat patient with advanced cancer

Simple intervention increases use of HIV medications in injection-drug users

Subcutaneous injection of new protein helps treat hemophilia more effectively

Single dose of cannabidiol showed effective results in rats with symptoms of depression

OSA patients have higher risk of developing gout, research reveals

Pfizer terminates clinical studies evaluating domagrozumab for treatment of Duchenne muscular dystrophy

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

HKBU chemists discover metal-based inhibitor to treat triple-negative breast cancer

Philips announces inclusion of iFR into ESC’s updated revascularization guidelines

Ultralaser treatment reduces pain in patients with fibromyalgia

New model could predict personalized waiting time for progression in colorectal cancer

Scientists explore DNA replication errors that can lead to cancer

Clinical trial: Promising drug slows brain shrinkage in progressive MS patients

Cancer-hunting stem cells may be potential drug delivery tool for medulloblastoma

Two Texas-based nonprofits named as recipients of ASTRO 2018 Survivor Circle grants

Three-pronged therapy triggers axons to regrow after spinal cord injury in rodents

Study yields therapeutic clues to combat drug resistance in rare aggressive cancer

Novel program offers new options for adult congenital heart patients

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News